CPRX - カタリスト・ファ―マシュ―ティカルズ (Catalyst Pharmaceuticals Inc.)

CPRXのニュース

   Catalyst (CPRX) Up 52.1% Since Last Earnings Report: Can It Continue?  2020/04/15 15:30:11 Zacks Investment Research
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   Catalyst's (CPRX) Q4 Earnings Miss Estimates, Revenues Meet  2020/03/17 10:35:00 Zacks Investment Research
Catalyst's (CPRX) earnings lag estimates in the fourth quarter. Revenues match the same.
   Catalyst Gives Preliminary Firdapse Estimates & Other Updates  2020/01/07 08:17:00 Zacks Investment Research
Catalyst (CPRX) provides preliminary estimates for Firdapse and other corporate updates for 2019.
   Why Is Catalyst (CPRX) Down 5.3% Since Last Earnings Report?  2019/12/12 16:30:19 Zacks Investment Research
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Why Is Catalyst (CPRX) Down 5.3% Since Last Earnings Report?  2019/12/12 16:30:19 Zacks Investment Research
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Catalyst Focuses on Firdapse Label Expansion Amid Competition  2019/11/29 08:39:00 Zacks Investment Research
Catalyst (CPRX) focuses on the development of Firdapse for additional indications.
   Catalyst Pharma (CPRX) to Post Q3 Earnings: What's in Store?  2019/10/29 08:46:00 Zacks Investment Research
During Catalyst's (CPRX) third-quarter 2019 conference call, investor focus will be on the sales performance of its only marketed drug Firdapse and its label expansion studies.
   Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock: Should You Buy?  2019/09/13 14:00:06 Zacks Investment Research
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
   Implied Volatility Surging for Catalyst (CPRX) Stock Options  2019/09/13 12:41:00 Zacks Investment Research
Investors need to pay close attention to Catalyst (CPRX) stock based on the movements in the options market lately.
   Catalyst Pharma +3.4% as director buys 20,000 shares  2018-12-14
Catalyst Pharmaceuticals (NASDAQ: CPRX ) is up 3.4% postmarket, after the disclosure that director Charles O'Keeffe bought 20,000 shares today. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more …

calendar